Thermo Fisher Scientific Inc.

NYSE:TMO

Medical - Diagnostics & Research

Healthcare
$692.74 +0.96%

+$4.45 today

Market cap
$256.67B
Beta
0.87
P/E (TTM)
25.3
EPS (TTM)
$18.44
Dividend yield
0.39%
52W Low $390.50High $643.99

Volume 1.99M

Average 2.23M

TMO Interest Income

Income earned on cash, deposits, and investments held by the company.

Thermo Fisher Scientific Inc.NYSE: TMO

Interest Income · Q3 FY2026 · quarter ended Sep 2026

Interest income growth accelerates

Q3 FY2026 interest income of $252M rose 7.7% year over year, ahead of the -1.1% change in trailing-twelve-month interest income. Sequentially, it rose 21.7% from the prior quarter. Over 3 fiscal years it compounded at +54.0% a year.

Context

  • Interest income amounted to 2.2% of revenue in FY2025, down 0.3 pp from a year earlier.
  • Interest income increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +7.7% holds above the trailing-twelve-month pace of -1.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$252M+21.7% QoQ
Last fiscal yearDec 2025
$993M-7.9% YoY
LTMSep 2026
$950M-1.1% YoY
Interest Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+7.7%——
1 year-7.9%——
3-year CAGR+54.0%——
5-year CAGR——
10-year CAGR——

Interest Income history

USD · from the income statement

Latest · FY2025
993M USD
Year-over-year change
-7.9%
4-year CAGR
+119.2%

Interest Income vs competitors

How TMO compares with its peers on the latest reported figures

  • TMO's LTM Sep 2026 interest income of $950M is the highest of the 10 companies compared; the peer median is $24.24M.
  • Its year-over-year change of -1.1% is the 3rd highest of 9, against a peer median of -25.4%.
  • Interest income amounts to 2.0% of revenue for TMO, versus a peer median of 0.5%.
TMO Competitors Peer median
Interest Income for TMO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TMOThermo Fisher Scientific Inc.LTM Sep 2026$950M -1.1%+54.0%2.0%
DHRDanaher CorporationLTM Sep 2026$132M +325.8%-9.9%0.5%
BIOBio-Rad Laboratories, Inc.LTM Jun 2026$88M +6.9%+18.1%3.4%
AAgilent Technologies, Inc.LTM Jul 2026$60M -13.0%+90.3%0.8%
QGENQiagen N.V.LTM Jun 2026$54.99M -12.1%+25.2%2.6%
RVTYRevvity, Inc.LTM Jul 2026$24.24M -52.5%+105.4%0.8%
WATWaters CorporationLTM Jul 2026$10.71M -37.8%-12.5%0.2%
BRKRBruker CorporationLTM Jun 2026$4.9M -52.4%+74.2%0.1%
TECHBio-Techne CorporationLTM Sep 2026$985K -74.9%—0.1%
MTDMettler-Toledo International Inc.LTM Jun 2026$0 ——0.0%
Peer median (excluding TMO) $24.24M-25.4%+25.2%0.5%

Competitors are the stored peer set for TMO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue39.21B44.92B42.86B42.88B44.56B
Cost of Revenue19.58B25.9B25.66B25.15B26.32B
Gross Profit19.63B19.01B17.19B17.73B18.24B
Gross Margin50.1%42.3%40.1%41.3%40.9%
Research & Development1.41B1.47B1.34B1.39B1.4B
Selling, General & Admin7.91B9.02B8.41B8.68B8.73B
Operating Expenses9.32B10.49B9.75B10.07B10.13B
Depreciation & Amortization2.59B3.38B3.41B3.11B2.78B
EBITDA11.97B11.94B11.2B11.8B11.47B
EBITDA Margin30.5%26.6%26.1%27.5%25.7%
Operating Income10.32B8.53B7.45B7.66B8.11B
Operating Margin26.3%19.0%17.4%17.9%18.2%
Interest Income43M272M879M1.08B993M
Interest Expense536M726M1.49B1.65B1.42B
Other Income / Expenses(1.48B)(862M)(1.21B)(667M)(842M)
Income Before Tax8.84B7.66B6.24B7B7.27B
Pre-Tax Margin22.5%17.1%14.6%16.3%16.3%
Income Tax Expense1.11B703M284M657M547M
Net Income7.73B6.95B6B6.34B6.74B
Net Margin19.7%15.5%14.0%14.8%15.1%
EPS (Basic)19.6117.7315.5316.5817.77
EPS (Diluted)19.4617.6415.4516.5317.74
Weighted Avg Shares394M392M386M382M376M
Weighted Avg Shares (Diluted)397M394M388M383M377M

Thermo Fisher Scientific Inc.

NYSE:TMO

Intrinsic Alpha fair value

Locked

Current Price

$692.74

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.